15.03.2015 Views

April 2012 Drug Information Update - Pharmacy Benefits ...

April 2012 Drug Information Update - Pharmacy Benefits ...

April 2012 Drug Information Update - Pharmacy Benefits ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

50 mg/mL, 10 mL vial, package of 10 (NDC 00409-2053-10)<br />

Ketalar injection, JHP<br />

10 mg/mL, 20 mL vials (NDC 42023-0113-10)<br />

Reason for the Shortage<br />

• JHP has Ketalar on shortage due to increased demand.<br />

• Mylan Institutional states the reason for the shortage is increased demand.<br />

• Hospira has ketamine on shortage due to manufacturing delays.<br />

• Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011.<br />

Product will become available in stages as production resumes.<br />

• Bedford Laboratories has multiple products affected by this suspension of manufacturing.<br />

Availability of all products, including those not manufactured at Ben Venue, is updated as<br />

information changes on the Bedford Laboratories website.<br />

Article link: http://www.ashp.org/<strong>Drug</strong>Shortages/Current/Bulletin.aspx?id=592<br />

Source: www.ashp.org<br />

Amphetamine Mixed Salts, Immediate-Release Tablets<br />

March 23, <strong>2012</strong><br />

Products Affected - Description<br />

Amphetamine mixed salts immediate-release tablets, Teva<br />

5 mg tablets, 100 count (NDC 00555-0971-02)<br />

7.5 mg tablets, 100 count (NDC 00555-0775-02)<br />

10 mg tablets, 100 count (NDC 00555-0972-02)<br />

12.5 mg tablets, 100 count (NDC 00555-0776-02)<br />

15 mg tablets, 100 count (NDC 00555-0777-02)<br />

20 mg tablets, 100 count (NDC 00555-0973-02)<br />

30 mg tablets, 100 count (NDC 00555-0974-02)<br />

Adderall, Teva<br />

5 mg tablets, 100 count (NDC 00555-0762-02)<br />

7.5 mg tablets, 100 count (NDC 00555-0763-02)<br />

10 mg tablets, 100 count (NDC 00555-0764-02)<br />

12.5 mg tablets, 100 count (NDC 00555-0765-02)<br />

15 mg tablets, 100 count (NDC 00555-0766-02)<br />

20 mg tablets, 100 count (NDC 00555-0767-02)<br />

30 mg tablets, 100 count (NDC 00555-0764-02)<br />

Amphetamine mixed salts immediate-release tablets, Sandoz<br />

5 mg tablets, 100 count (NDC 00185-0084-01)<br />

10 mg tablets, 100 count (NDC 00185-0111-01)<br />

20 mg tablets, 100 count (NDC 00185-0401-01)<br />

30 mg tablets, 100 count (NDC 00185-0404-01)<br />

Amphetamine mixed salts immediate-release tablets, CorePharma<br />

5 mg tablets, 100 count (NDC 64720-0130-10)<br />

10 mg tablets, 100 count (NDC 64720-0132-10)<br />

20 mg tablets, 100 count (NDC 64720-0135-10)<br />

30 mg tablets, 100 count (NDC 64720-0136-10)<br />

Reason for the Shortage<br />

• Teva states the shortage is due to DEA quota restrictions.<br />

• CorePharma cannot provide a reason for the shortage.<br />

• Sandoz states the shortage is due to increased demand.<br />

59

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!